Researchers developed a transient reporter gene assay in zebrafish liver cells to study the xenobiotic metabolism pathway and found that viral, constitutive promoters can cause signal silencing, a phenomenon they term 'squelching'.
Cell Biology and Toxicology · 3 authors, 1 centre
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
Researchers developed a transient reporter gene assay in zebrafish liver cells to study the xenobiotic metabolism pathway and found that viral, constitutive promoters can cause signal silencing, a phenomenon they term 'squelching'.
This preclinical study developed and characterized a transient reporter gene assay in the zebrafish liver cell line (ZFL) to monitor the AhR xenobiotic metabolism pathway. The researchers identified that synthetic, constitutive promoters can interfere with reporter signal transduction through a 'squelching' phenomenon, leading to artificial signal inhibition. The work also characterized the response of zebrafish cells to the ligand beta-naphthoflavone (BNF), finding it promiscuously activates multiple pathways and can lead to multi-level inhibition termed 'maisonette squelching'. A key limitation is the low responsiveness of the zebrafish system to AhR-mediated effects, which may limit its utility for predicting low-dose effects.